Recent Articles
Here’s Why Facebook Stock Will Ride Out Yet Another Storm
Facebook again is at the center of controversy. But past scandals haven't dented FB stock. Shares will rally through this controversy, too.
Buying Chesapeake Stock Is like Setting Money on Fire
It's only a matter of time before Chesapeake stock makes its way to zero. Investors should stay clear of this debt-laden energy firm.
Investors Should Root for a Dip in Shopify Stock
SHOP stock has retreated from May highs, and seems to have plateaued after a monster rally. Investors taking the long view should be happy.
Best Buy Stock Is Still a Buy With or Without Coronavirus Tailwinds
Best Buy stock has come roaring back to life. That's as business goes on as usual and as the company hangs tough.
A Rare 100X Opportunity in This Vital Sector
The stakes for getting this right could not be higher. COVID-19 has sickened more than seven million people around the world so far, and at least 405,400 people have lost their lives to the pandemic. Innovative biotechnology companies have stepped up to the plate and are racing to create what could become a life-saving treatment for hundreds of thousands in the form of a vaccine. I’m optimistic we could see one as soon as the end of the year. The speed with which vaccine efforts got underway shows how far science has come. Researchers are currently working on 224 candidates , according to the Coalition for Epidemic Preparedness Innovations. About 10 of those have advanced to human trials.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
